LY6G6D
Lymphocyte antigen 6 complex locus protein G6d
Also known as: C6orf23, G6D, Ly6-D, LY66D_HUMAN, MEGT1, NG25
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O95868
- Gene
- LY6G6D
- Ensembl
- ENSG00000244355
- Chromosome
- 6
- Canonical length
- 133 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
- Secretome location
- Intracellular and membrane
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This locus represents naturally occurring readthrough transcription between the neighboring LY6G6F (lymphocyte antigen 6 family member G6F) and LY6G6D (lymphocyte antigen 6 family member G6D) genes on chromosome 6. The readthrough transcript encodes a fusion protein that shares sequence identity with each individual gene product. [provided by RefSeq, Jul 2017]
Canonical amino-acid sequenceUniProt
133 residues, UniProt reviewed canonical sequence.
>O95868|LY6G6D
1 MKPQFVGILL SSLLGAALGN RMRCYNCGGS PSSSCKEAVT TCGEGRPQPG LEQIKLPGNP
61 PVTLIHQHPA CVAAHHCNQV ETESVGDVTY PAHRDCYLGD LCNSAVASHV APAGILAAAA
121 TALTCLLPGL WSGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LY6G6D can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.42
- Highest tissue expression
- 34 nTPM
Expression across tissuesHPA
Tissue
- skin: 34 nTPM
- seminal vesicle: 6.3 nTPM
- colon: 5 nTPM
- prostate: 3.3 nTPM
- cervix: 2.2 nTPM
- vagina: 1.5 nTPM
Single-cell type
- platelets: 2.8 nCPM
- neuroendocrine cells: 0.5 nCPM
- suprabasal keratinocytes: 0.3 nCPM
- breast secretory cells: 0.1 nCPM
- megakaryocyte progenitors: 0.1 nCPM
- prostatic glandular cells: 0.1 nCPM
Immune cell
- intermediate monocyte: 0.1 nTPM
- non-classical monocyte: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- cerebral cortex: 0.3 nTPM
- basal ganglia: 0.2 nTPM
- midbrain: 0.2 nTPM
- spinal cord: 0.2 nTPM
- amygdala: 0.1 nTPM
- cerebellum: 0.1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.26
- gnomAD pLI
- 0.03
- gnomAD missense Z
- 0.1
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LY6G6D as an antibody target. Whether an autoantibody or antibody against LY6G6D could matter depends on whether native LY6G6D is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LY6G6D is annotated at the cell surface, where native LY6G6D is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label LY6G6D as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...